Patents Represented by Attorney Millen, White, Zelano, Branigan, P.C.

Find this attorney in the Justia Lawyer Directory

  • Amorphous transparent conductive film, target and production method for amorphous conductive film
    Patent number: 8153033
    Abstract: An amorphous transparent conductive film containing as a main component a six oxygen-coordinated metal oxide, and satisfying, in a radial distribution function (RDF) obtained by an X-ray scattering measurement, a relationship of A/B>1, providing that the maximum value of RDF at an interatomic distance of from 0.30 nm to 0.36 nm is A and the maximum value of RDF at an interatomic distance of from 0.36 nm to 0.42 nm is B.
    Type: Grant
    Filed: March 7, 2006
    Date of Patent: April 10, 2012
    Assignee: Idemitsu Kosan Co., Ltd.
    Inventors: Yukio Shimane, Kazuyoshi Inoue, Masato Matsubara, Nobuo Tanaka, Tokie Tanaka, legal representative, Shigekazu Tomai, Koki Yano, Shigeo Matsuzaki
  • In-Ga-Zn-Sn type oxide sinter and target for physical film deposition
    Patent number: 8153031
    Abstract: An oxide sintered body including an indium element (In), a gallium element (Ga), a zinc element (Zn) and a tin element (Sn), and including a compound shown by Ga2In6Sn2O16 or (Ga,In)2O3.
    Type: Grant
    Filed: November 30, 2007
    Date of Patent: April 10, 2012
    Assignee: Idemitsu Kosan Co., Ltd.
    Inventors: Koki Yano, Kazuyoshi Inoue
  • Organic thin film transistor and organic thin film light-emitting transistor
    Patent number: 8154014
    Abstract: The present invention aims to provide an organic thin film transistor that is superior in stability in the atmosphere and that has a high operation speed.
    Type: Grant
    Filed: August 29, 2008
    Date of Patent: April 10, 2012
    Assignee: Idemitsu Kosan, Co., Ltd.
    Inventors: Ichiro Tanaka, Hideji Osuga
  • 3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes
    Patent number: 8153649
    Abstract: Novel compounds of the formula (I), in which W, T, R1, R2, R3, R4, R5 and R6 have the meanings indicated in Patent Claim (1), are suitable as antidiabetics.
    Type: Grant
    Filed: September 27, 2007
    Date of Patent: April 10, 2012
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Markus Klein, Rolf Gericke, Norbert Beier, Bertram Cezanne, Christos Tsaklakidis, Werner Mederski
  • Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
    Patent number: 8147824
    Abstract: Isolated cells are described that are not embryonic stem cells, not embryonic germ cells, and not germ cells. The cells can differentiate into at least one cell type of each of at least two of the endodermal, ectodermal, and mesodermal lineages. The cells do not provoke a harmful immune response. The cells can modulate immune responses. As an example, the cells can suppress an immune response in a host engendered by allogeneic cells, tissues, and organs. Methods are described for using the cells, by themselves or adjunctively, to treat subjects. For instance, the cells can be used adjunctively for immunosuppression in transplant therapy. Methods for obtaining the cells and compositions for using them also are described.
    Type: Grant
    Filed: November 9, 2005
    Date of Patent: April 3, 2012
    Assignees: Athersys, Inc., Oregon Health and Science University
    Inventors: Richard Maziarz, Magdalena Kovacsovics, Philip Streeter, Robert Deans, Wouter Van't Hof
  • Oxonium and sulfonium salts
    Patent number: 8148443
    Abstract: The present invention relates to oxonium salts having [(Ro)3O]+ cations and sulfonium salts having [(Ro)3S]+ cations, where Ro denotes straight-chain or branched alkyl groups having 1-8 C atoms or phenyl which is unsubstituted or substituted by Ro, ORo, N(Ro)2, CN or halogen, and anions selected from the group of [PFx(CyF2y+1?xHz)6?x]? anions, where 2?x?5, 1?y?8 and 0?z?2y+1, or anions selected from the group of [BFn(CN)4?n]? anions, where n=0, 1, 2 or 3, or anions selected from the group of [(Rf1SO2)2N]? anions or anions selected from the group of [BFWRf24?w]? anions, to processes for the preparation thereof, and to the use thereof, in particular for the preparation of ionic liquids.
    Type: Grant
    Filed: October 20, 2010
    Date of Patent: April 3, 2012
    Assignee: Merck Patent Gesellschaft Mit Beschrankter Haftung
    Inventors: Nikolai (Mykola) Ignatyev, German Bissky, Helge Willner
  • Tricyclic aromatics and liquid-crystalline medium
    Patent number: 8148551
    Abstract: The invention relates to tricyclic aromatics of the general formula I in which A1, A2, A3, A4, Q1-Q2, R1, R2, X1, X2, X3, Z1, Z2, Z3, Z4, q, r, s, t and u have the meaning indicated, and to the use thereof as components of liquid-crystalline media and to an electro-optical display element containing same.
    Type: Grant
    Filed: December 29, 2006
    Date of Patent: April 3, 2012
    Assignee: Merck Patent Gesellschaft MIT Beschraenkter Haftung
    Inventors: Rudolf Eidenschink, Holger Kretzschmann
  • Bimetallic or multi-metallic catalyst that has an optimized bimetallicity index and an optimized hydrogen adsorption capacity
    Patent number: 8148288
    Abstract: The invention relates to a catalyst that comprises a metal M from the group of platinum, at least one promoter X1 that is selected from the group that consists of tin, germanium, and lead, and optionally at least one promoter X2 that is selected from the group that consists of gallium, indium and thallium, a halogenated compound and a porous substrate, in which the atomic ratio X1/M and optionally X2/M is between 0.3 and 8, the Hir/M ratio that is measured by hydrogen adsorption is greater than 0.40, and the bimetallicity index BMI that is measured by hydrogen/oxygen titration is greater than 108. The invention also relates to the process for the preparation of this catalyst and a reforming process using said catalyst.
    Type: Grant
    Filed: December 7, 2007
    Date of Patent: April 3, 2012
    Assignee: IFP Energies Nouvelles
    Inventors: Pierre-Yves Le Goff, Fabienne Le Peltier, Jean Giraud, Sylvie Lacombe, Christophe Chau
  • Articulated extraction pipe
    Patent number: 8146653
    Abstract: The invention concerns a bore screen comprising a plurality of perforated rigid tubular modules (1) impermeably connected in series by ball joint means (2), allowing an extracted fluid to flow though all of the elements in series and allowing the consecutive elements to move freely relative to one another, tilting in all directions.
    Type: Grant
    Filed: August 1, 2007
    Date of Patent: April 3, 2012
    Assignee: Euroslot KDSS France
    Inventor: Abdol Hossein Naderi
  • Combined etching and doping media
    Patent number: 8148191
    Abstract: The present invention relates firstly to HF/fluoride-free etching and doping media which are suitable both for the etching of inorganic layers and also for the doping of underlying layers. The present invention secondly also relates to a process in which these media are employed.
    Type: Grant
    Filed: October 7, 2008
    Date of Patent: April 3, 2012
    Assignee: Merck Patent GmbH
    Inventors: Sylke Klein, Armin Kübelbeck, Werner Stockum, Wilfried Schmidt, Berthold Schum
  • Organic thin film transistor and organic thin film light-emitting transistor
    Patent number: 8148720
    Abstract: An organic thin film transistor including a substrate having thereon at least three terminals of a gate electrode, a source electrode and a drain electrode, an insulator layer and an organic semiconductor layer, with a current between a source and a drain being controlled upon application of a voltage to the gate electrode, wherein the organic semiconductor layer includes a specified organic compound having an acetylene or olefin structure in the center thereof; and an organic thin film light emitting transistor utilizing an organic thin film transistor, wherein the organic thin film transistor is one in which light emission is obtained utilizing a current flowing between the source and the drain, and the light emission is controlled upon application of a voltage to the gate electrode, and is made high with respect to the response speed and has a large ON/OFF ratio, are provided.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: April 3, 2012
    Assignee: Idemitsu Kosan Co., Ltd.
    Inventors: Masatoshi Saito, Yuki Nakano, Hiroaki Nakamura
  • Multilayer structure comprising at least one stabilized layer
    Patent number: 8147935
    Abstract: The invention relates to a multilayer structure comprising at least two layers: a layer, referred to as the inner layer, intended to be in contact with a fluid, comprising a composition comprising at least one polymer and not comprising any copper, and a layer, referred to as the outer layer, intended to be in contact with the air, comprising a composition containing at least one polymer and at least one copper-based stabilizer. The invention also relates to a pipe comprising such a multilayer structure, and also to its use for transporting or storing fluids.
    Type: Grant
    Filed: March 2, 2009
    Date of Patent: April 3, 2012
    Assignee: Arkema France
    Inventors: Vincent Ferreiro, Thibaut Montanari, Fabrice Montezin
  • Use of ionic liquids for membrane protein extraction
    Patent number: 8143381
    Abstract: The present invention relates to the use of ionic liquids or of mixtures comprising at least one ionic liquid and at least one further solvent for the extraction of membrane proteins from biological samples, to methods for the extraction of membrane proteins, to a kit for the extraction of these proteins and to the use thereof.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: March 27, 2012
    Assignee: Merck Patent GmbH
    Inventors: Joerg Von Hagen, Uwe Michelsen, Maria Wehsling
  • Printable etching media for silicon dioxide and silicon nitride layers
    Patent number: 8143172
    Abstract: The present invention relates to a novel printable etching medium having non-Newtonian flow behavior for the etching of surfaces in the production of solar cells, and to the use thereof. The present invention furthermore also relates to etching and doping media which are suitable both for the etching of inorganic layers and also for the doping of underlying layers. In particular, they are corresponding particle-containing compositions by means of which extremely fine structures can be etched very selectively without damaging or attacking adjacent areas.
    Type: Grant
    Filed: June 21, 2006
    Date of Patent: March 27, 2012
    Assignee: Merck Patent GmbH
    Inventors: Werner Stockum, Armin Kuebelbeck, Jun Nakanowatari
  • Salts having alkoxytris(fluoroalkyl)borate anions
    Patent number: 8143452
    Abstract: The invention relates to salts having alkoxytris(fluoroalkyl)borate anions which on the one hand are used for the synthesis of ionic liquids, but on the other hand can be employed per se as ionic liquid, and to processes for the preparation thereof.
    Type: Grant
    Filed: March 2, 2010
    Date of Patent: March 27, 2012
    Assignee: Merck Patent GmbH
    Inventors: Nikola (Mykola) Ignatyev, Urs Welz-Biermann, Maik Finze, Eduard Bernhardt, Helge Willner
  • Method for recycling plastic materials and use thereof
    Patent number: 8138232
    Abstract: The invention relates to a method for recycling plastic materials which contain at least two polymers, copolymers or blends thereof based on polystyrene. The plastic material is thereby mixed with a solvent for the polymers, copolymers or blends. Subsequently a precipitation is effected by addition of a corresponding precipitant so that then the gelatinous precipitation product can be separated from the further components of the plastic material. The method is used for recycling of any plastic materials, in particular of plastic materials from electronic scrap processing and from shredder light fractions.
    Type: Grant
    Filed: June 8, 2006
    Date of Patent: March 20, 2012
    Assignee: Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung E.V.
    Inventors: Andreas Maeurer, Martin Schlummer, Otto Beck
  • Process for producing middle distillates by hydroisomerizing and hydrocracking feeds from the fischer-tropsch process
    Patent number: 8137532
    Abstract: The invention concerns a process for producing middle distillates from a paraffinic feed produced by Fischer-Tropsch synthesis, using a hydrocracking/hydroisomerization catalyst which comprises 0.2% to 2.5% by weight of an oxide of a doping element selected from boron, phosphorus, silicon, at least one hydrodehydrogenating element selected from the group formed by noble elements from group VIII of the periodic table, a non-zeolitic support based on silica-alumina containing more than 5% by weight and 95% by weight or less of silica (SiO2), specifically defined pore characteristics, a BET specific surface area in the range 100 to 550 m2/g, and with an X ray diffraction diagram which contains at least the characteristic principal peaks of at least one of the transition aluminas included in the group composed of alpha, rho, khi, eta, gamma, kappa, theta and delta aluminas.
    Type: Grant
    Filed: December 14, 2006
    Date of Patent: March 20, 2012
    Assignee: IFP Energies Nouvelles
    Inventors: Patrick Euzen, Christophe Gueret
  • Oxaphenanthrene derivatives
    Patent number: 8133887
    Abstract: The invention relates to compounds of the formula (I), in which R1, R2, R3, R4, Y and A have the meanings indicated, and to processes for the preparation thereof and to the use thereof for the preparation of medicaments.
    Type: Grant
    Filed: November 29, 2006
    Date of Patent: March 13, 2012
    Assignee: Merck Patent GmbH
    Inventors: Andreas Taugerbeck, Detlef Pauluth, Beate Kretschmer, Hanns Wurziger, Axel Jansen, David Maillard
  • Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
    Patent number: 8134003
    Abstract: The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (indazoles and benzothiazoles), which act as ligands for the ?7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
    Type: Grant
    Filed: May 9, 2011
    Date of Patent: March 13, 2012
    Assignee: Memory Pharmaceuticals Corporation
    Inventors: Wenge Xie, Brian Herbert, Truc Nguyen, Carla Gauss, Ashok Tehim
  • Substituted indeno [1,2-b]indole derivatives as novel inhibitors of protein kinase CK2 and their use as tumor therapeutic agents, cytostatics and diagnostic aids
    Patent number: 8133913
    Abstract: Synthesis of novel substituted indeno[1,2-b]indole derivatives of the type of 5,6,7,8-tetrahydroindeno[1,2-b]indole-9,10-diones and 5H-indeno[1,2-b]indole-6,9,10-triones, which show pronounced inhibition of the human protein kinase CK2, and the use thereof as active ingredients in medicaments and/or drug products in particular for the treatment of neoplastic diseases.
    Type: Grant
    Filed: October 4, 2007
    Date of Patent: March 13, 2012
    Assignee: Heinrich-Heine Universitat Dusseldof
    Inventors: Hans-Jorg Hemmerling, Claudia Gotz, Joachim Jose